Shots:
- PharmaShots’ May Edition explores how AI is transforming commercial strategies across the healthcare ecosystem by enabling predictive analytics, personalized engagement, dynamic launch planning, and real-time omnichannel optimization while balancing compliance and measurable ROI.
- The magazine highlights key industry movements shaping global biopharma, including AI-driven drug discovery collaborations, strategic M&A activity, advancements in cell and gene therapy commercialization, regulatory momentum in chronic disease therapies, and the growing integration of machine learning across R&D and commercial operations.
- Featuring thought leadership, cover stories, regulatory insights, and innovation spotlights including Eli Lilly and Company CEO David A. Ricks, insitro, and Dupixent, the issue showcases how AI, precision engagement, and data-driven decision-making are redefining the future of biopharma innovation and commercialization.
